EUROPEAN SOCIETY FOR HYBRID, MOLECULAR AND TRANSLATIONAL IMAGING

CHILI 2019

  • 20 LECTURES
  • 304 MINUTES
  • 12 SPEAKERS
  • ESR MEMBERS €19
  • NON-MEMBERS €29

Learning Objectives

  1. to learn the principles of hybrid medical imaging
  2. to learn the key clinical questions at different points in the patient’s journey
  3. to understand the indications, limitations and comparative merits of each part in hybrid medical imaging in a wide range of oncologic and non-oncologic conditions, including prostate cancer, breast cancer, esophageal cancer as well as inflammation and infection.
  4. to appreciate the complementary roles of structural and functional/molecular imaging in cancer management
  5. to understand how information derived from imaging guides patient selection for treatment and supports individualised treatment planning
  6. to learn about advanced applications of hybrid imaging, such as theranostics, new radiopharmaceuticals and machine learning in hybrid imaging

Content

The four sessions at CHILI are ascending in level, tailored to your own degree of expertise and interests. All sessions include 3 lectures of approx. 20 minutes and end with a round table discussion.
Session 1 – The basics of hybrid imaging
Hybrid imaging – an introductionThomas Beyer
18F-FDG PET/CT in oncology – basic considerationsBarbara Malene Fischer
Pitfalls in 18F-FDG PET/CTJosé L. Vercher-Conejero
Round Table Discussion
 
Session 2 – Clinical application of hybrid imaging I
PET/CT for therapy management of breast cancer patientsMyriam Wartski
The role of PET/CT in esophageal cancerPatrick Veit-Haibach
Hybrid PET in inflammation and infectionJean-Noël Talbot
Round Table Discussion
 
Session 3 – Clinical application of hybrid imaging II
Hybrid imaging in paediatricsHelen Nadel
Monitoring immunotherapy with hybrid imagingClemens Cyran
PSMA hybrid imaging: guiding clinical management in prostate cancerKatrine Riklund
Round Table Discussion
 
Session 4 – Advanced applications in hybrid imaging
Evidence of theranostics in neuroendocrine tumours and prostate cancerHarun Ilhan
New horizons: PET and SPECT innovations from the radiochemistry labAlexander Hammers
Machine learning in imaging: With or without hybrid imaging?Irène Buvat
Round Table Discussion
 

Categories and Tags

  • ADVANCED

Speakers

Presenter

Thomas Beyer

Vienna, Austria

Presenter

Barbara Malene Fischer

London, United Kingdom

Presenter

José L. Vercher-Conejero

Barcelona, Spain

Presenter

Myriam Wartski

Paris, France

Presenter

Patrick Veit-Haibach

Toronto, Canada

Presenter

Jean-Noël Talbot

Paris, France

Presenter

Helen Nadel

Stanford, United States

Presenter

Clemens Cyran

Munich, Germany

Presenter

Katrine Riklund

Umeå, Sweden

Presenter

Harun Ilhan

Munich, Germany

Presenter

Alexander Hammers

London, United Kingdom

Presenter

Irène Buvat

Orsay, France